Dr. Lu is a Research Assistant Professor of Medical Oncology at the University of Washington. She received her MD from Sun Yat-sen University of Medical Sciences in China and her PhD in Toxicology from the University of Washington in Seattle. Before joining TVG, she had two years of post-doctoral training with Dr. Jan Storek in the Clinical Research Division of Fred Hutchinson Cancer Research Center, where she studied the effect of interleukin-7 (IL-7) on immune reconstitution. Dr. Lu joined TVG in 2003. Her research interest focuses on pre-clinical development of novel immunotherapeutic approaches for breast cancer. Two of her previous projects have been translated into clinical trials via collaboration with other investigators in the TVG, including the use of topical imiquimod for breast cancer patients with cutaneous metastasis and the use of TLR agonists to enhance natural killer (NK) cell function for enhanced anti-tumor immunity. Dr. Lu has a particular interest in studying the immune modulatory effects of natural products. Her study on the immune enhancing effects of polysaccharide-K (PSK) is funded by the NCI and NCCAM. She has active collaboration with Dr. Leanna Standish in Bastyr University and serves as a mentor for Bastyr’s T32 training program on Complementary and Alternative (CAM) therapy. Her long-term goal is to develop combinatorial therapies for cancer patients that combine standard cancer treatment, immunotherapy, and CAM.
Research Assistant Professor, Division of Oncology at the UW